- Telehealth visits
K. Pallav Kolli, MD
Interventional Radiology • RadiologyDirector of Operations, Interventional Radiology- Telehealth visits
K. Pallav Kolli, MD
Interventional Radiology • RadiologyDirector of Operations, Interventional Radiology- Telehealth visits
On this page
About me
Dr. K. Pallav Kolli is an interventional radiologist, a medical imaging specialist who uses minimally invasive techniques to care for patients with cancer and other disorders.
Kolli's research interests include MRI guidance for interventional procedures, including those to treat cancer and disorders involving blood vessels.
Kolli earned his medical degree from the Feinberg School of Medicine at Northwestern University. At UCSF, he completed a residency in diagnostic radiology, followed by a fellowship in vascular and interventional radiology.
Kolli is a member of the Radiological Society of North America, Society of Interventional Radiology and American Roentgen Ray Society. He is associate chair for quality and safety with the UCSF Department of Radiology and Biomedical Imaging.
Education & training
Board certification
- Interventional and Diagnostic Radiology, American Board of Radiology
Fellowship
- Vascular & Interventional Radiology, UCSF School of Medicine -GME
Residency
- Diagnostic Radiology, UCSF School of Medicine -GME
Internship
- Transitional, McGaw Medical Center of Northwestern University
Degree
- MD, Northwestern University Feinberg School of Medicine
Academic Title
- Clinical Professor
My expertise
Specialties
- Interventional Radiology
- Radiology
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.